Abstract: A process of producing 8a- and 9a- azalide compounds is disclosed, comprised of reacting an 8a- aza or 9a- aza azalide eastern fragment or a derivative thereof with a compound of the formula:X--A'--Ywherein X and Y are appropriate reactive groups and A' is a fragment or compound which forms the western portion of the azalide, andcyclizing this intermediate to form the target 8a- or 9a-azalide compound. Compounds of formula I, II and III as well as other azalides can be synthesized according to this process.
Type:
Grant
Filed:
April 14, 1993
Date of Patent:
July 26, 1994
Assignee:
Merck & Co., Inc.
Inventors:
Sherman T. Waddell, Timothy A. Blizzard
Abstract: Antifungal and antiparasital lipopeptide compounds stable in aqueous media are described. Stability in aqueous media render lipopeptides more useful for compositions for therapeutic applications.
Abstract: A cyclohexapeptide base which is the nucleus of closely related antibiotics obtained by culturing Zalerion arboricola and its salts are described. They are useful intermediates for the preparation of new semisynthetic compounds having antimicrobial activity.
Type:
Grant
Filed:
March 12, 1990
Date of Patent:
May 10, 1994
Assignee:
Merck & Co., Inc.
Inventors:
Dennis M. Schmatz, Jan S. Tkacz, Robert E. Schwartz, Mervyn Turner
Abstract: An organism of the Sporormiella species produces a compound having the formula ##STR1## which is useful. The compound is useful as an antifungal agent.
Abstract: Carbapenems of the formula ##STR1## wherein a suitably substituted aza-9-fluorenone is attached at the 2-position of the carbapenem are useful antibacterial agents.
Type:
Grant
Filed:
October 15, 1992
Date of Patent:
March 15, 1994
Assignee:
Merck & Co. Inc.
Inventors:
Frank P. DiNinno, Ravindra N. Guthikonda
Abstract: Compounds having the formula ##STR1## wherein R and R.sup.1 may be H or COCH.sub.3 provided that when R.sup.1 is COCH.sub.3, R is COCH.sub.3 are described.
Type:
Grant
Filed:
October 19, 1992
Date of Patent:
January 4, 1994
Assignee:
Merck & Co., Inc.
Inventors:
Angeles Cabello, Guy Harris, Robert A. Giacobbe, Gregory L. Helms, Otto D. Hensens, Suzanne M. Mandala, E. Tracy T. Jones, Isabel Martin, Walter Rozdilsky
Abstract: Dicarbonyloxy, carbonyloxy, carbanilate, and dihydroxy derivatives of Virginiamycin M.sub.1 are useful antibiotics and effectively bind gastrin and brain CCK receptors.
Abstract: Compounds of the formula: ##STR1## where R is hydrogen, C.sub.1 -C.sub.10 alkylcarbonyl, or C.sub.1 -C.sub.10 alkyl which can be substituted by amino or cyano, R.sup.1 and R.sup.2 are independently hydrogen, hydroxyl or amino, and the pharmaceutically aceptable salts and esters thereof. Pharmaceutical compositions and methods of their use are also provided for.
Abstract: Carbapenems of the formula ##STR1## wherein: P' is a removable protecting group for hydroxy; andM is a removable protecting group for carboxy;are useful intermediates for carbapenem antibiotics.
Type:
Grant
Filed:
April 16, 1991
Date of Patent:
May 25, 1993
Assignee:
Merck & Co., Inc.
Inventors:
Frank DiNinno, Thomas A. Rano, Mark L. Greenlee
Abstract: A method of making compounds of the formulae: ##STR1## wherein X is ##STR2## R.sup.1 is hydrogen, methyl, C.sub.1-10 alkoxycarbonyl or arylsulfonyl when X is CH.sub.3 CH.sub.2 CHNH.sub.2 and is additionally aralkoxycarbonyl when X is NH.sub.2 ; one of R.sup.2 and R.sup.3 is hydrogen and the other is OH, NHR.sup.1 or NMeR.sup.1 where R.sup.1 is as defined above; R.sup.4 is hydrogen or C.sub.1-10 alkyl when X is CH.sub.3 CH.sub.2 CHNH.sub.2 and is additionally aralkyl when X is NH.sub.2 ; R.sup.5 is hydrogen or C.sub.1-3 alkyl when X is CH.sub.3 CH.sub.2 CHNH.sub.2 ; R.sup.5 is hydrogen when X is NH.sub.2 ; one of R6 and R7 is hydrogen and the other is methyl except when X is CH.sub.3 CH.sub.2 CHNH.sub.2 and R.sup.2 is H, in which case R.sup.6 is methyl and R.sup.7 is hydrogen. These compounds are made from erythromycin-derived fragments of the formulae: ##STR3## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are defined as before for when X is NH.sub.2 ; R.sup.5 is hydrogen or C.sub.1-3 alkyl; if R.sup.
Type:
Grant
Filed:
August 26, 1992
Date of Patent:
May 11, 1993
Assignee:
Merck & Co., Inc.
Inventors:
Sherman T. Waddell, Timothy A. Blizzard
Abstract: Carbapenems of the formula ##STR1## wherein: P' is a removable protecting group for hydroxy; and M is a removable protecting group for carboxy; are useful intermediates for carbapenem antibiotics.
Type:
Grant
Filed:
April 16, 1991
Date of Patent:
May 4, 1993
Assignee:
Merck & Co., Inc.
Inventors:
Frank DiNinno, Mark L. Greenlee, Thomas A. Rano
Abstract: Novel compounds and compositions which inhibit SRS-A in mammals are disclosed. Methods for preparing said compounds and compositions and methods for their use for treating allergic reactions, inflammation and for reducing the severity of myocardial infarction resulting from heart attack are disclosed.Useful intermediates for preparing said compounds are also disclosed.
Type:
Grant
Filed:
July 28, 1987
Date of Patent:
January 29, 1991
Assignee:
Schering Corporation
Inventors:
Anil K. Saksena, Jesse K. Wong, Pietro Mangiaracina